CLINICAL_TRIALS
trial_result
· 2021-09-27
Clinical Trial Update: Study to Evaluate LB1148 for Return of Gastrointestinal Function, Decrease Post-Operative Ileus [Phase 2]
Summary
Phase 2 trial update for LB1148 evaluating return of GI function and reduction of postoperative ileus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Newsoara Biopharma Co., Ltd. | Conditions: Ileus | Phase 2 | Status: COMPLETED